Li et al. demonstrated that the expression of noncoding RNA growth arrest-specific transcript 5 (GAS5) in circulating exosomes (Exo-GAS5) could be an ideal non-invasive blood-based tumor marker for the identification of patients with early-stage NSCLC. Here, GAS5 is linked to neoplasm.